PLG-0206

DB18116InvestigationalProtein Based Therapies

PLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections.

Code names
PLG-0206 · WLBU-2

Resolves to

What you can answer from here — as of December 24, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of PLG-0206, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account